Weigert

Wei·gert

(vī'gert),
Carl, German pathologist, 1845-1904. See: Weigert law, Weigert iodine solution. See entries under stain
References in periodicals archive ?
Weigert said the version identifies root causes of supply chain expenses by leading member users through an analysis that focuses on changes that have the greatest bottom line impact.
We have seen a huge demand from major and regional banks, hedge funds, custodians, asset managers and other market participants looking for dedicated third party data feeds for risk management and are delighted to have helped Nordea to meet this acute challenge," said Danny Weigert, Head of Revaluation Center, SuperDerivatives.
Dedo Weigert, Depu Jin and Franz Petters for the Dedolight 400D
We have the technology that truly brings the power of data to bear to improve patient care and to reduce supply chain costs," said Marla Weigert, Premier Group Vice President.
The City of Chicago, through our Retrofit Chicago initiative, is reducing energy use in commercial, residential and municipal buildings," said Karen Weigert, chief sustainability officer for the City of Chicago.
We continue to enhance and refresh SpendAdvisor by leveraging member feedback and extensive usability testing," said Premier Group Vice President Marla Weigert.
We are leveraging more than three years of experience and proven results from our members as to how to best derive savings from advanced spend analytics," said Premier Group Vice President Marla Weigert.
Agency : Landkreis Neuburg-Schrobenhausen, vertreten durch den Landrat Herrn Roland Weigert
Dani Weigert, manager of the SuperDerivatives Revaluation Center said, "We welcome Fulcrum to the leading group of fund administrators who count on our revaluation services for providing top quality service to their own fund clients.
Tenders are invited for Supply Of 16 Types Of Electrical Spares At Sse/Tm/Nagpur Plasser/ Panasonic/BCH/ Schrack/ Tyco Electronics/Schneider/ Parker/Teknic/ mPm/Turck/Deutz/ VDO/ Pricol/ Gossen Muller & Weigert (GMW) / Knitter
TSX VENTURE: IXS) (OTCBB: IXSBF), a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL[TM]) technology, today announced that Martin Weigert, Ph.
Premier Group Vice President Marla Weigert said, "One of our primary roles is to bring cutting-edge technology solutions to systemic problems that inhibit the efficiency and cost-effective delivery of healthcare in the communities our members serve.